The JointJYNT -7.49%63 EV-to-FCF is 38.72 as of Jun. 28, 2026, which is 7% below its 10-year median of 41.48. GuruFocus rates JYNT with a GF Score™ of 63/100 and a GF Value™ of $11.11 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 410 Healthcare Providers & Services companies, The Joint ranks worse than 82.2% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, The Joint's Enterprise Value is $102.84 Mil.
The Joint's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $2.66 Mil. Therefore, The Joint's EV-to-FCF for today is 38.72.
The historical rank and industry rank for The Joint's EV-to-FCF or its related term are showing as below:
JYNT'
s EV-to-FCF Range Over the Past 10 Years
Min: -2290.47 Med: 41.48 Max: 377.51
Current: 38.72
During the past 13 years, the highest EV-to-FCF of The Joint was 377.51. The lowest was -2290.47. And the median was 41.48.
JYNT's EV-to-FCF is ranked worse than 82.2% of 410
companies
in the Healthcare Providers & Services industry
Industry Median: 17.435
vs JYNT: 38.72
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
The Joint's share price for today is $8.52.
The Joint's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.230.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
The Joint EV-to-FCF Related Terms
The Joint EV-to-FCF Historical Data
* Premium members only.
The historical data trend for The Joint's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, The Joint's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Joint EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, The Joint's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where The Joint's EV-to-FCF falls into.
The Joint's current Enterprise Value is $102.84 Mil.
The Joint's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.66 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Joint (JYNT) has a EV-to-FCF of 38.72 as of Jun. 28, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on The Joint and its competitors. This is near median its historical median of 41.48. According to the industry distribution chart, The Joint ranks #337 out of 410 companies in the Healthcare Providers & Services industry, placing it in the top 82.2%.
Is The Joint's EV-to-FCF too high?
The Joint's current EV-to-FCF of 38.72 is near median its 10-year median of 41.48. The Healthcare Providers & Services industry median EV-to-FCF is 17.44. The Joint's value of 38.72 is 122.1% above this industry median. Based on the distribution chart, The Joint ranks #337 out of 410 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, The Joint has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Joint's EV-to-FCF compare to MAHN and WW?
According to the Healthcare Providers & Services industry distribution chart, The Joint ranks #337 out of 410 companies for EV-to-FCF. This places The Joint in the lower half of its industry. The industry median EV-to-FCF is 17.44. The Joint's value of 38.72 is 122.1% above this benchmark. While the company's 10-year median is 41.48 vs. the industry median of 17.44, The Joint has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.44, based on 410 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Joint's current EV-to-FCF of 38.72 is 122.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on The Joint and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Joint's current EV-to-FCF is 38.72, which is near median its own 10-year median of 41.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Joint stock overvalued right now?
Based on GuruFocus' analysis, The Joint (JYNT) is currently considered Modestly Undervalued. The stock's GF Value™ is $11.11, compared to a current price of $8.52 — trading 23.3% below its estimated fair value. The current EV-to-FCF is 38.72, which is near median its 10-year median of 41.48 and 122.1% above the Healthcare Providers & Services industry median of 17.44. The Joint's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For The Joint (JYNT), the current EV-to-FCF is 38.72 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Joint (JYNT) Overvalued in 2026?
Based on GuruFocus' analysis, The Joint stock appears to be undervalued.
The current stock price of $8.52 is trading 23.3% below its estimated GF Value™ of $11.11.
GuruFocus considers The Joint to be Modestly Undervalued.
Key valuation signals for JYNT:
EV-to-FCF: 38.72 (near median its 10-year median of 41.48)
GF Value™: $11.11 vs. price of $8.52 (23.3% below fair value)
Industry Position: 122.1% above the Healthcare Providers & Services median (#337 of 410)
No single metric tells the full story. See the JYNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.
63GF Score
Get the complete analysis for JYNT
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JYNT has been successfully added to your 
